Home Tags Posts tagged with "sinopharm"

sinopharm

China’s Sinovac Covid vaccine has been approved by the World Health Organization (WHO) for emergency use.

Sinovac is the second Chinese vaccine to receive the green light from the WHO, after Sinopharm.

The WHO approval opens the door for the vaccine to be used in the Covax program, which aims to ensure fair access to vaccines.

Sinovac, which has already been used in several countries, has been recommended for over 18s, with a second dose two to four weeks later.

The emergency approval means the Chinese vaccine “meets international standards for safety, efficacy and manufacturing”, the WHO said.

Studies showed that Sinovac prevented symptomatic disease in more than half of those vaccinated and prevented severe symptoms and hospitalization in 100% of those studied, it added.

It is hoped that the decision to list the Chinese vaccine for emergency use will give a boost to the Covax initiative, which has been struggling with supply problems.

“The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe,” said Mariangela Simao, the WHO’s assistant director general for access to health products.

“We urge manufacturers to participate in the Covax facility, share their know-how and data and contribute to bringing the pandemic under control,” she said.

As well as China, Sinovac is already being administered in countries including Chile, Brazil, Indonesia, Mexico, Thailand and Turkey.

Sinovac says it has supplied more than 600 million doses at home and abroad as of the end of May. It says more than 430 million doses have been administered.

US to Share 60 Million Doses of AstraZeneca Covid Vaccine with Other Countries

One of Sinovac’s main advantages is that it can be stored in a standard refrigerator at 2-8 degrees Celsius. This means Sinovac is a lot more useful to developing countries which might not be able to store large amounts of vaccine at low temperatures.

The emergency approval came as the heads of the WHO, the World Trade Organization, the International Monetary Fund and the World Bank appealed for a $50 billion investment fund to help end the pandemic.

In a joint statement they said the world had reached a perilous point, and that inequalities in access to vaccines risked prolonging the pandemic, and many more deaths.

They have called for the money to be invested in areas including vaccine production, oxygen supplies, and Covid-19 treatments, ensuring they are distributed fairly.

They also called on wealthy countries to donate vaccine doses immediately to developing nations.

Image source: Wikimedia Commons

Hungary is the first country in the EU to give preliminary approval to the Russian coronavirus vaccine, Sputnik V.

On January 21, PM Viktor Orban’s chief of staff confirmed both the Russian vaccine and the Oxford-AstraZeneca vaccine had been given the green light by the health authorities.

Foreign Minister Peter Szijjarto is travelling to Russia for further talks, where he is expected to discuss a shipment and distribution deal.

Early results from trials of the Russian vaccine have shown promising results.

Hungarian health officials are also in Beijing for talks with the Chinese authorities over the approval and immediate delivery of one million doses of the Sinopharm vaccine, which is already being used in neighboring Serbia.

Sinopharm, a Chinese state-owned company, announced last month that phase three trials of its vaccine showed that it was 79% effective – lower than that of Pfizer and Moderna.

However, PM Viktor Orban has said the only way Hungary can satisfy the demand for vaccination, given the “frustratingly” slow delivery of the Pfizer-BioNTech vaccine, is by buying from Russia and China.

Coronavirus: AstraZeneca and Sputnik V Vaccines to Be Combined in New Trial

Sputnik V: Russian Coronavirus Vaccine Shows to Produce Antibody Response

At least 140,000 Hungarians have already been vaccinated. But government efforts to popularize the Russian and Chinese vaccines have already run into opposition.

The skepticism and suspicion among Hungarians is, in the public imagination at least, related to the Communist domination of the country from 1948 to 1989.

The move has also drawn criticism from the EU, which is wary of yet another example of Viktor Orban’s government going its own way and undermining EU solidarity.

Katalin Kariko, a Hungarian biochemist who left the country for the United States in 1985, played a key role in developing the Pfizer-BioNTech vaccine.

Some polls suggest only seven percent of Hungarians would accept the Sputnik V vaccine, while acceptance of the Chinese version has been measured as low as one percent by some surveys.

Russia is funding and building a major expansion of Hungary’s nuclear power station at Paks. The Chinese Fudan University is also due to open a campus in Budapest in 2024, and plans are advancing for a high-speed Chinese railway that would link Budapest to Thessaloniki and bring Chinese goods to Europe.

According to recent reports, 6,000 doses of the Sputnik V vaccine will be administered to 3,000 paid Hungarian volunteers in phase three of a clinical trial in the coming weeks.